Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create life-saving therapeutics, today announced the expansion of its board …